Cancer Research UK logo.
SearchDonate
  • Search

A trial of selinexor, cyclophosphamide and prednisolone for myeloma (MUK twelve)

Overview

Cancer types:

Blood cancers, Myeloma

Status:

Closed

Phase:

Phase 2

Details

This trial is for people whose myeloma has come back or treatment has stopped working.

Recruitment start: 1 April 2018

Recruitment end: 17 June 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Martin Kaiser

Supported by

University of Leeds

Myeloma UK

Karyopharm Therapeutics

Last reviewed: 30 July 2024

CRUK internal database number: 16101

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.